Sigilon Therapeutics, Inc. Quarterly Depreciation, Depletion and Amortization in USD from Q1 2020 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Sigilon Therapeutics, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2020 to Q2 2023.
  • Sigilon Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending June 30, 2023 was $300K, unchanged year-over-year.
  • Sigilon Therapeutics, Inc. Depreciation, Depletion and Amortization for the twelve months ending June 30, 2023 was $1.26M, a 6.4% increase year-over-year.
  • Sigilon Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2022 was $1.26M, a 13.1% increase from 2021.
  • Sigilon Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2021 was $1.12M, a 30.9% increase from 2020.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $1.26M $300K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $1.26M $315K -$1K -0.32% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $1.26M $348K +$77K +28.4% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-14
Q3 2022 $1.19M $300K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $1.19M $300K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $1.19M $316K +$69K +27.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $1.12M $271K +$19K +7.54% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 $1.1M $300K +$100K +50% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $999K $300K +$100K +50% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $899K $247K +$45K +22.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $854K $252K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $200K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $200K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $202K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.